We only have this paper's title and publication details.
Read it at the sourcePreclinical study demonstrates enhanced immune protection against Leishmania major in vaccinated mice, highlighting LPD nanoparticles as a promising vaccine delivery platform.
No takes yet. Share an insight, caveat, or question.
Firouzmand et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: